Beyond Competitors

Stocks . USA . 
Stock . Beyond Medical Technologies
DOCKF Stock  USD 0.26  0.09  52.94%   
Beyond Medical Techn competes with Bion Environmental, Questor Technology, Environmmtl Tectonic, China High, and Avante Logixx; as well as few others. The company classifies itself under Machinery sector and is part of Industrials industry. Analyzing Beyond Medical competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Beyond Medical to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Beyond Medical Correlation with its peers.

Beyond Medical vs White Fox Correlation

Very good diversification

The correlation between Beyond Medical Technologies and AWAW is -0.37 (i.e., Very good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Beyond Medical Technologies and AWAW in the same portfolio, assuming nothing else is changed.

Moving against Beyond Stock

  0.31DDD 3D SystemsPairCorr
At this time, Beyond Medical's Return On Capital Employed is most likely to increase slightly in the upcoming years. The Beyond Medical's current Return On Equity is estimated to increase to 0.0004, while Return On Tangible Assets are projected to decrease to (0.02). At this time, Beyond Medical's Fixed Asset Turnover is most likely to increase in the upcoming years.
Specify up to 10 symbols:
Hype
Prediction
LowEstimatedHigh
0.010.2462.24
Details
Intrinsic
Valuation
LowRealHigh
0.010.1962.19
Details

Beyond Medical Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Beyond Medical and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Beyond and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Beyond Medical Techn does not affect the price movement of the other competitor.

High positive correlations

BNET
+ 0.77
INTWF
ALXXF
+ 0.6
QUTIF
CHSTY
+ 0.52
QUTIF
ALXXF
+ 0.49
BNET
ALXXF
+ 0.49
CHSTY
AWAW
+ 0.47
ETCC
  

High negative correlations

ALXXF
- 0.81
ETCC
AWAW
- 0.7
ALXXF
ETCC
- 0.67
BNET
ETCC
- 0.52
INTWF
APGI
- 0.5
CHSTY
AWAW
- 0.49
CHSTY

Risk-Adjusted Indicators

There is a big difference between Beyond Stock performing well and Beyond Medical Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Beyond Medical's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
INTWF  8.60  1.94  0.14 (5.06) 8.00 
(15.03)
 25.00 
(17.42)
 61.11 
BNET  6.66  1.13  0.09  2.12  6.82 
(11.33)
 14.29 
(15.00)
 34.54 
QUTIF  1.48  0.14  0.00 (0.05) 0.00 
 0.00 
 0.00 
 0.00 
 44.44 
PRBCF  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
ETCC  1.92 (0.74) 0.00  5.08  0.00 
 0.00 
 3.65 
(5.22)
 13.33 
EFTI  32.25  17.46  0.00 (0.91) 0.00 
 0.00 
 0.00 
 0.00 
 0.00 
CHSTY  1.11  0.60  0.00 (0.65) 0.00 
 0.00 
 0.00 
 0.00 
 33.81 
ALXXF  0.98  0.52  0.00 (0.78) 0.00 
 0.00 
 0.00 
 0.00 
 29.85 
APGI  3.15 (0.18) 0.00 (0.51) 0.00 
 0.00 
 16.67 
(14.29)
 34.29 
AWAW  11.91  1.76  0.05 (0.48) 13.83 
(63.10)
 30.00 
(40.00)
 233.33 

Beyond Medical Competitive Analysis

The better you understand Beyond Medical competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Beyond Medical's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Beyond Medical's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
DOCKF INTWF BNET QUTIF PRBCF ETCC CHSTY ALXXF APGI AWAW
 52.94 
 0.26 
Beyond
 4.17 
 0.10 
Sharc
 10.00 
 0.27 
Bion
 0.00 
 0.39 
Questor
 0.00 
 0.36 
Precise
 1.10 
 0.90 
Environmmtl
 0.00 
 5.62 
China
 0.00 
 0.87 
Avante
 3.33 
 0.01 
American
 57.92 
 0.05 
White
Market Volatility
(90 Days Market Risk)
Out of control
Out of control
Out of control
Out of control
Very steady
Dangerous
Moderately volatile
Extremely Dangerous
Out of control
Out of control
Market Performance
(90 Days Performance)
Good
Good
Good
Weakest
Weakest
Weakest
Fair
Fair
Weakest
Soft
Odds of Financial Distress
(Probability Of Bankruptcy)
Strong
Small
High
Low
Hazard
Small
Low
Average
Risky
Risky
Current Valuation
(Equity Enterprise Value)
Over Valued
Over Valued
Over Valued
Over Valued
Over Valued
Fairly Valued
Under Valued
Over Valued
Fairly Valued
Over Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Not Available
Trade Advice
(90 Days Macroaxis Advice)
Strong Hold
Cautious Hold
Strong Hold
Cautious Hold
Not Rated
Cautious Hold
Cautious Hold
Cautious Hold
Hold
Cautious Hold
Current Ratio
3.73
0.91
1.7
5.83
1.23
1.39
1.41
2.94
0.25
0.55
Net Asset
13.8 K
5.97 M
6.36 M
35.05 M
241.05 M
N/A
29.64 B
42.94 M
9.79 M
177.07 K
Profit Margin
N/A
-2.05
N/A
-0.33
-0.15
0.0816
0.0266
0.0696
N/A
N/A
EBITDA
(773.19 K)
(1.81 M)
8.59 M
(2.32 M)
(13.13 M)
(1.63 M)
2.29 B
(4.19 M)
(4.98 M)
N/A
Current Valuation
3.88 M
23.62 M
47.07 M
14.12 M
17.35 M
4.5 M
375.36 M
5.97 M
9.77 M
1.04 M
Price To Book
6.04
77.28
N/A
1.16
2.69
1.49
0.46
1.1
N/A
N/A
Operating Margin
N/A
-1.59
N/A
-0.46
N/A
-0.13
0.0711
0.0326
-2.54
-43.67
Retained Earnings
(26.38 M)
N/A
(120.75 M)
N/A
N/A
(13.43 M)
4.61 B
N/A
(71.59 M)
(9.74 M)
Current Asset
N/A
N/A
81 K
N/A
107 M
28.62 M
19.5 B
N/A
2.02 M
172 K
Beta
9214.12
0.26
0.22
1.85
1.1
0.59
0.62
1.54
0.4
1.32
Number Of Employees
N/A
16
7
8
28
203
6.3 K
126
8
7
Shares Outstanding
32.49 M
107.19 M
43.63 M
27.85 M
46.43 M
9.16 M
65.41 M
26.49 M
79.89 M
73.68 M
Cash Flow From Operations
(109.77 K)
(2.59 M)
(670.78 K)
(1.13 M)
(1.49 M)
2.35 M
(1.48 B)
1.82 M
(3.85 M)
(2.35 M)
Annual Yield
N/A
N/A
N/A
N/A
N/A
N/A
0.0362
N/A
N/A
N/A
Total Debt
60 K
3.07 M
5.17 M
517.77 K
N/A
15.01 M
4 B
8.42 M
4.89 M
518.02 K
Return On Equity
-3.14
-18.37
N/A
-0.0839
-0.12
0.79
0.0565
-0.16
N/A
N/A
Z Score
N/A
4.2
-14.1
23.4
N/A
0.6
N/A
1.2
-9.8
-81.2
Return On Asset
-0.2
-0.43
-0.34
-0.0643
-0.0404
-0.0516
0.0266
0.0113
-0.43
-2.69
Book Value Per Share
0.0434
-0.008
-0.036
1.08
0.044
0.042
161.9
0.7
-0.078
-0.014
Number Of Shares Shorted
N/A
N/A
N/A
N/A
N/A
5.47 K
N/A
N/A
N/A
N/A
Current Liabilities
N/A
N/A
11.12 M
N/A
19 M
33.54 M
15.27 B
N/A
4.63 M
905 K
Total Asset
13.8 K
5.97 M
6.36 M
35.05 M
241.05 M
42.26 M
29.64 B
42.94 M
9.79 M
177.07 K
Debt To Equity
0.042
N/A
-2.2
0.017
0.33
N/A
0.29
0.038
N/A
N/A
Target Price
27.98
N/A
3.0
N/A
N/A
N/A
N/A
N/A
0.5
35.0
Short Ratio
N/A
N/A
N/A
N/A
N/A
0.13
N/A
N/A
N/A
N/A
Shares Owned By Institutions
N/A
N/A
0.09
14.9
3.08
N/A
N/A
N/A
N/A
N/A
Market Capitalization
17.87 M
21.97 M
79.4 M
20.65 M
30.64 M
17.4 M
771.86 M
18.71 M
1.79 M
1.03 M
Price To Earning
38.84
72.5
6.2
535.9
39.3
13.33
4.67
139.3
-0.05
N/A
Price To Sales
1.41
11.19
5654.91
3.27
2.77
0.88
0.0496
0.77
0.57
10.25
Net Income
(285.94 K)
(3.04 M)
8.29 M
(3.99 M)
(13.45 M)
1.81 M
1.32 B
(4.39 M)
(7.56 M)
(9.4 M)
Earnings Per Share
-0.07
-0.024
0.18
-0.1
-0.006
0.05
1.15
-0.032
-0.15
-0.13
Shares Owned By Insiders
34.88
12.31
28.41
17.88
25.98
N/A
N/A
66.8
43.28
2.08
Revenue
N/A
2.7 M
N/A
5.5 M
83.32 M
21.8 M
20.21 B
18.16 M
1.86 M
77.19 K
Working Capital
(620.66 K)
N/A
(11.04 M)
N/A
88 M
(4.92 M)
4.23 B
N/A
(2.62 M)
(733 K)
Cash And Equivalents
877.31 K
1.95 M
3.16 M
14.88 M
10.28 M
393 K
6.96 B
12.09 M
212.17 K
248.68 K
Cash Per Share
0.01
0.02
0.07
0.54
0.03
0.03
106.37
0.46
N/A
N/A
Gross Profit
(250.49 K)
959.96 K
N/A
(999.21 K)
63.54 M
4.32 M
3.19 B
7.85 M
(1.19 M)
(469.86 K)
Day Typical Price
0.26
0.098
0.27
0.39
0.36
0.9
5.62
0.87
0.0062
0.0405
Accumulation Distribution
N/A
184.71
N/A
N/A
N/A
3.3
N/A
N/A
N/A
0.59
Market Facilitation Index
N/A
0.0
N/A
N/A
N/A
0.0
N/A
N/A
N/A
0.03
Daily Balance Of Power
9.2 T
0.6557
0
0.0
0.0
(1.00)
0.0
0.0
9.2 T
(2.32)
Period Momentum Indicator
0.09
0.004
(0.03)
N/A
N/A
(0.01)
N/A
N/A
2.0E-4
(0.07)
Rate Of Daily Change
1.53
1.04
0.9
1.0
1.0
0.99
1.0
1.0
1.03
0.42
Day Median Price
0.26
0.097
0.27
0.39
0.36
0.91
5.62
0.87
0.0062
0.0355
Price Action Indicator
0.045
0.0051
(0.01)
N/A
N/A
(0.01)
N/A
N/A
1.0E-4
(0.02)
Coefficient Of Variation
687.95
644.4
788.65
10508.69
N/A
(358.21)
774.6
774.6
(4,676)
1970.81
Mean Deviation
22.78
8.6
6.66
1.48
N/A
1.92
1.11
0.9784
3.15
11.91
Jensen Alpha
7.83
1.94
1.13
0.1371
N/A
(0.74)
0.6046
0.5249
(0.18)
1.76
Total Risk Alpha
3.97
0.9934
0.4754
(0.51)
N/A
(0.95)
0.2293
0.2013
(0.70)
(0.74)
Sortino Ratio
0.1353
0.1382
0.0909
N/A
N/A
N/A
N/A
N/A
N/A
0.0463
Downside Variance
3563.08
180.12
146.87
N/A
N/A
N/A
N/A
N/A
N/A
1060.3
Standard Deviation
56.03
12.4
9.24
7.78
N/A
2.65
4.36
3.85
7.21
31.09
Kurtosis
21.76
1.31
0.9519
29.83
N/A
0.8355
60.0
60.0
3.98
27.86
Potential Upside
52.94
25.0
14.29
N/A
N/A
3.65
N/A
N/A
16.67
30.0
Treynor Ratio
1.61
(5.06)
2.12
(0.05)
N/A
5.08
(0.65)
(0.78)
(0.51)
(0.48)
Maximum Drawdown
381.88
61.11
34.54
44.44
N/A
13.33
33.81
29.85
34.29
233.33
Variance
3139.2
153.82
85.43
60.59
N/A
7.01
19.05
14.85
51.97
966.44
Market Risk Adjusted Performance
1.62
(5.05)
2.13
(0.04)
N/A
5.09
(0.64)
(0.77)
(0.50)
(0.47)
Risk Adjusted Performance
0.1272
0.1346
0.1114
0.0166
N/A
(0.22)
0.1123
0.1121
(0.01)
0.0507
Skewness
4.32
0.7792
0.3956
0.8549
N/A
0.3059
7.75
7.75
(0.21)
4.36
Semi Deviation
17.33
8.0
6.82
N/A
N/A
N/A
N/A
N/A
N/A
13.83
Information Ratio
0.1441
0.1495
0.1192
5.0E-4
N/A
(0.31)
0.1131
0.111
(0.03)
0.0485
Value At Risk
(36.00)
(17.42)
(15.00)
N/A
N/A
(5.22)
N/A
N/A
(14.29)
(40.00)
Expected Short fall
(82.54)
(15.03)
(11.33)
N/A
N/A
N/A
N/A
N/A
N/A
(63.10)
Downside Deviation
59.69
13.42
12.12
N/A
N/A
N/A
N/A
N/A
N/A
32.56
Semi Variance
300.46
64.0
46.53
N/A
N/A
N/A
N/A
N/A
N/A
191.18

Beyond Medical Competition Performance Charts

Five steps to successful analysis of Beyond Medical Competition

Beyond Medical's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Beyond Medical Techn in relation to its competition. Beyond Medical's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Beyond Medical in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Beyond Medical's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Beyond Medical Techn, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Beyond Medical position

In addition to having Beyond Medical in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Industrials ETFs Thematic Idea Now

Industrials ETFs
Industrials ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Industrials ETFs theme has 55 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Industrials ETFs Theme or any other thematic opportunities.
View All  Next Launch
When determining whether Beyond Medical Techn is a strong investment it is important to analyze Beyond Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Beyond Medical's future performance. For an informed investment choice regarding Beyond Stock, refer to the following important reports:
How To Invest In Beyond
Details
Is Beyond Stock a good investment?
Details
What is Beyond Medical's Net Worth?
Details
Largest Industrial Machinery & Supplies & Components Companies
View
Largest Pollution & Treatment Controls Companies
View
Check out Beyond Medical Correlation with its peers.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Can Industrial Machinery & Supplies & Components industry sustain growth momentum? Does Beyond have expansion opportunities? Factors like these will boost the valuation of Beyond Medical. Projected growth potential of Beyond fundamentally drives upward valuation adjustments. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Beyond Medical demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share
(0.07)
Revenue Per Share
(0)
Quarterly Revenue Growth
(0.92)
Return On Assets
(0.20)
Return On Equity
(3.14)
Investors evaluate Beyond Medical Techn using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Beyond Medical's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. External factors like market trends, sector rotation, and investor psychology can cause Beyond Medical's market price to deviate significantly from intrinsic value.
Altman
Z Score
Details
Piotroski
F Score
Details
Beneish
M Score
Details
Financial
Analysis
Details
Buy or Sell
Advice
Details
Technical
Analysis
Details
It's important to distinguish between Beyond Medical's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Beyond Medical should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Beyond Medical's market price signifies the transaction level at which participants voluntarily complete trades.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY